EXTL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.39328606616618E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.49500001267455E-09 |
Normal-vs-Stage2 |
2.16369999999078E-05 |
Normal-vs-Stage3 |
2.7556845694221E-12 |
Normal-vs-Stage4 |
8.14903700074865E-14 |
Stage1-vs-Stage2 |
4.893200E-01 |
Stage1-vs-Stage3 |
1.382300E-03 |
Stage1-vs-Stage4 |
1.7441399999929E-05 |
Stage2-vs-Stage3 |
2.712800E-01 |
Stage2-vs-Stage4 |
5.172000E-02 |
Stage3-vs-Stage4 |
2.086000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.73592259958377E-12 |
Normal-vs-AfricanAmerican |
1.06319997250637E-09 |
Normal-vs-Asian |
1.301550E-02 |
Caucasian-vs-AfricanAmerican |
1.867780E-01 |
Caucasian-vs-Asian |
8.483600E-01 |
AfricanAmerican-vs-Asian |
7.181800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.84185999785313E-13 |
Normal-vs-Female |
4.76739980825869E-10 |
Male-vs-Female |
1.393750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.761300E-04 |
Normal-vs-Age(41-60Yrs) |
1.54799995044641E-09 |
Normal-vs-Age(61-80Yrs) |
1.6565637750432E-12 |
Normal-vs-Age(81-100Yrs) |
1.70936999999149E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.728000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.555800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.596200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.318000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.668400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.233600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.498800E-01 |
Normal-vs-Grade 2 |
2.0963000000318E-06 |
Normal-vs-Grade 3 |
1.06947783962141E-12 |
Normal-vs-Grade 4 |
1.62836411021772E-12 |
Grade 1-vs-Grade 2 |
2.486600E-01 |
Grade 1-vs-Grade 3 |
5.180900E-04 |
Grade 1-vs-Grade 4 |
1.169680E-04 |
Grade 2-vs-Grade 3 |
4.09609999996174E-06 |
Grade 2-vs-Grade 4 |
1.97330000006879E-07 |
Grade 3-vs-Grade 4 |
8.458200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.12949999999212E-05 |
Normal-vs-ccB subtype |
1.68842717584994E-12 |
ccA subtype-vs-ccB subtype |
1.01170000044171E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.0170000114561E-09 |
Normal-vs-N1 |
4.83029999998053E-06 |
N0-vs-N1 |
8.577900E-02 |
|
|